Correlation Between LianBio ADR and Lyra Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both LianBio ADR and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LianBio ADR and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LianBio ADR and Lyra Therapeutics, you can compare the effects of market volatilities on LianBio ADR and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LianBio ADR with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LianBio ADR and Lyra Therapeutics.

Diversification Opportunities for LianBio ADR and Lyra Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between LianBio and Lyra is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding LianBio ADR and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and LianBio ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LianBio ADR are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of LianBio ADR i.e., LianBio ADR and Lyra Therapeutics go up and down completely randomly.

Pair Corralation between LianBio ADR and Lyra Therapeutics

If you would invest (100.00) in LianBio ADR on December 27, 2024 and sell it today you would earn a total of  100.00  from holding LianBio ADR or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

LianBio ADR  vs.  Lyra Therapeutics

 Performance 
       Timeline  
LianBio ADR 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days LianBio ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, LianBio ADR is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Lyra Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

LianBio ADR and Lyra Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with LianBio ADR and Lyra Therapeutics

The main advantage of trading using opposite LianBio ADR and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LianBio ADR position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.
The idea behind LianBio ADR and Lyra Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum